Background: End stage renal disease (ESRD) patients are at increased risk of coronary atherosclerosis and cardiovascular mortality. The metabolic changes associated with ESRD place them at risk for osteodystrophy and osteoporosis. It may be prudent to assess the risk of atherosclerosis and osteoporosis in such patients. This is usually performed by using coronary artery calcium (CAC) scans and imaging studies of lumbar spine using multidetector computed tomography (MDCT) and dual energy x-ray absorptiometry (DXA). This study looks at the prospect of using CAC scans for osteoporosis and atherosclerosis risk assessment.
